Literature DB >> 3584474

Gangliosides shed by tumor cells enhance tumor formation in mice.

S Ladisch, S Kitada, E F Hays.   

Abstract

The role of tumor cell membrane gangliosides in tumor formation was probed using a series of cloned murine AKR lymphoma cell lines. Tumor formation was directly related to high expression and shedding of membrane gangliosides. In vivo, as little as 1 pmol of purified total gangliosides of highly tumorigenic cells, injected intradermally with poorly tumorigenic cells (which lacked and did not shed gangliosides), markedly increased the tumorigenicity of these cells in syngeneic normal mice. Thus, gangliosides shed by tumor cells are a previously unrecognized, extremely potent enhancer of tumor formation in vivo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584474      PMCID: PMC424533          DOI: 10.1172/JCI113031

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Long-chain neutral glycolipids and gangliosides of murine fibroblast lines and their low- and high-tumourigenic hybrids.

Authors:  K Itaya; S I Hakomori; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  Poly-2-vinylpyridine N-oxide reverses the immunosuppressive effects of silica and carrageenan.

Authors:  A Rios; R L Simmons
Journal:  Transplantation       Date:  1972-03       Impact factor: 4.939

Review 3.  The concept of immunological surveillance.

Authors:  F M Burnet
Journal:  Prog Exp Tumor Res       Date:  1970

4.  Modulation of the immune response by antigen-reactive lymphocytes after cultivation with gangliosides.

Authors:  H C Miller; W J Esselman
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

Review 5.  Shedding from the cell surface of normal and cancer cells.

Authors:  P H Black
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

6.  Incorporation of asialo GM2 and gangliosides in cell surface of cultured metastatic and nonmetastatic BALB/3T3 cell lines: subcutaneous tumor cell take.

Authors:  G Yogeeswaran
Journal:  J Natl Cancer Inst       Date:  1981-02       Impact factor: 13.506

7.  Inhibition of the lectin-induced mitogenic response of thymocytes by glycolipids.

Authors:  E E Lengle; R Krishnaraj; R G Kemp
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

8.  Regulation of lymphocyte responses by human gangliosides. I. Characteristics of inhibitory effects and the induction of impaired activation.

Authors:  R L Whisler; A J Yates
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

Review 9.  Biosynthesis and function of gangliosides.

Authors:  P H Fishman; R O Brady
Journal:  Science       Date:  1976-11-26       Impact factor: 47.728

10.  Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines.

Authors:  P T Mora; R O Brady; R M Bradley; V W McFarland
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

View more
  33 in total

1.  Serum immunoassay of a small cell lung cancer associated ganglioside: development of a sensitive scintillation proximity assay.

Authors:  T Pallesen; A Vangsted; L Drivsholm; H Clausen; J Zeuthen; H Wallin
Journal:  Glycoconj J       Date:  1992-12       Impact factor: 2.916

2.  Intracellular regulation of the production and release of human erythroid-directed lymphokines.

Authors:  N Dainiak; S Sorba
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

3.  Induction of leukocyte infiltration at metastatic site mediates the protective effect of NGcGM3-based vaccine.

Authors:  Mayrel Labrada; Isabel Pablos; Francesca Prete; Giselle Hevia; Marilyn Clavell; Federica Benvenuti; Luis E Fernández
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Exogenously administered gangliosides fail to increase in vivo metastatic frequency or in vitro growth of murine neoplastic cells.

Authors:  L Facci; S D Skaper; D Presti; G Kirschner; A Leon; L Chieco-Bianchi
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

5.  Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma.

Authors:  T J Yang; T J Palker; M W Harding
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation.

Authors:  J W Chu; F J Sharom
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

7.  Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.

Authors:  Purna Mukherjee; Anthony C Faber; Laura M Shelton; Rena C Baek; Thomas C Chiles; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2008-02-20       Impact factor: 5.922

8.  Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth.

Authors:  Y Liu; S Yan; A Wondimu; D Bob; M Weiss; K Sliwinski; J Villar; V Notario; M Sutherland; A M Colberg-Poley; S Ladisch
Journal:  Oncogene       Date:  2010-03-22       Impact factor: 9.867

9.  Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.

Authors:  Thomas N Seyfried; Purna Mukherjee
Journal:  J Oncol       Date:  2010-06-20       Impact factor: 4.375

10.  Gangliosides regulate tumor cell adhesion to collagen.

Authors:  Tamara Kazarian; Adnan A Jabbar; Fei-Qui Wen; Dharmesh A Patel; Leonard A Valentino
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.